References
- Young L. S. Empirical antimicrobial therapy in the neutropenic host. New England Journal of Medicine 1986; 315: 580–581
- Klastersky J. Concept of empiric therapy with antibiotic combinations: indications and limits. American Journal of Medicine 1986; 80: 2–12
- The GIMEMA Infection Program. Prevention of bacterial infection in neutropenic patients with hematologic malignancies. A randomized, multicenter trial comparing norfloxacin with ciprofloxacin. Annals of Internal Medicine 1991; 115: 7–12
- Menichetti F., Felicini R., Bucaneve G., Aversa F., Greco M., Pasquarella C., Moretti M. V., Del Favero A., Martelli M. F. Norfloxacin prophylaxis for neutropenic patients undergoing bone marrow transplantation. Bone Marrow Transplantation 1989; 4: 489–492
- Kureishi A., Jewesson P. J., Rubinger M., Cole C. D., Reece D. E., Phillips G. L., Smith J. A., Chow A. W. Double-blinde comparison of teicoplanin versus vancomycin in febrile neutropenic patients receiving concomitant tobramycin and piperacillin: effect on cyclosporin A-associated nephrotoxicity. Antimicrobial Agents and Chemotherapy 1991; 35: 2246–2252
- Del Favero A., Menichetti F., Guerciolini R., Bucaneve G., Baldelli F., Aversa F., Terenzi A., Davis S., Pauluzzi S. Prospective randomized clinical trial of teicoplanin for empiric combined antibiotic therapy in febrile, granulocytopenic acute leukemia patients. Antimicrobial Agents and Chemotherapy 1987; 31: 1126–1129